Navigation Links
Hope for major advance in fighting world killer disease

University of Leicester scientists are heading a worldwide research project which could revolutionise the diagnosis and treatment of diarrhoea in children in developing countries.

The four-year project, the results of which are now being piloted in four hospitals in India, will offer a means of identifying the two most deadly forms of the disease quickly, cheaply and with little training necessary for practitioners.

The implications for improving children's health could be enormous. Diarrhoea is a major killer in developing countries. World Health Organisation statistics indicate that more than 2 million people die each year from the effects of diarrhoea, most of them children under five years old.

Diarrhoea is caused by a range of bacterial, viral and parasitic organisms, and is usually spread by contaminated water and poor sanitation. Two particular bacteria , enteropathogenic E.coli (EPEC), which causes a persistent infection lasting more than 14 days, and Shigella, the cause of dysentery - are the most deadly in terms of killing children. They cause only 20% of cases of diarrhoea but result in 60% of deaths. It is these two killers - EPEC and Shigella - that the Leicester-led project is targeting.

Peter Williams, Professor of Microbiology in the Department of Genetics, and Leicester colleagues Uta Praekelt and Marie Singer, are working with scientists at the Robert Koch Institute in Germany and Anna University in Chennai India, and with doctors at the Christian Medical College in Vellore, India, and at Gadjah Mada University in Yogyakarta, Indonesia.

Their project, called the European-Asian Challenge to Childhood Diarrhoea, or EACh-ChilD (because each child is precious!) currently receives funding of ?m from the European Union, but in its earlier stages it was supported by an Academic Links Scheme funded by the British Council and the Indian University Grants Commission.

Professor Williams commented:
'"/>

Source:University of Leicester


Page: 1 2 3

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. Researchers uncover sequence of major rice pathogen
3. Emergence of cancer as major cause of childhood death in developing countries is not being adequately addressed
4. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
5. Virologists make major step towards understanding the process of HIV infection
6. Biota makes major antiviral discovery
7. New gene scanning technology marks a major advance in disease research
8. LIAI scientists make major finding on potential smallpox treatment
9. MicroRNAs have shaped the evolution of the majority of mammalian genes
10. MIT: Oceans are a major gene swap-meet for plankton
11. U-M scientists identify major psoriasis susceptibility gene

Post Your Comments:
(Date:11/23/2009)... Iowa - The only swine vaccine available for the H...infected with the virus. The vaccination marks the...diagnosed with the pandemic flu., Iowa State Uni..., developed the vaccine this summer and has been s...a, Kansas and Illinois for several weeks., The l...
(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...
(Date:11/23/2009)...ional Institute of General Medical Sciences (NIGMS..., is investing $42.3 million for grants in scienti...O)." NIH developed the GO grant program to stimula... provided by the American Recovery and Reinvestmen...ects that promise to have a significant impact on ...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Platelet Rich Plasma 3A Does It Work 3F 58657 1Platelet Rich Plasma 3A Does It Work 3F 58657 2Platelet Rich Plasma 3A Does It Work 3F 58657 3Platelet Rich Plasma 3A Does It Work 3F 58657 4DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 1DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 2Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 1Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 2
...urned on to target and destroy foreign infectious ...n, it is just as important to turn the immune syst.... The fruit fly Drosophila has served as a good mo..., pointing to conserved pathways and mechanisms. R...more subtly regulated and produces a wider range o...
...ld at the University of Edinburgh, 3-6 September 2... fingers, faeces and flies: food and waterborne pa...s. , Hepatitis E virus (HEV), which can be fatal,...veloping countries but scientists in the Netherlan...e contracting the virus from pork. It is one of fe...
...els in coastal waters interfere with fish reproduc...cientist from The University of Texas at Austin Ma...seasonal low levels of oxygen, known as hypoxia, h...ghout the world over the past few decades, largely...ultural and industrial activities. Hypoxias long-t...
Other Biology News:Society for General Microbiology 161st Meeting, University of Edinburgh 2Low oxygen in coastal waters impairs fish reproduction 2
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...Newswire-Asia/--ShanghaiBiolaxyannouncedthe,Chines...the,investigationalnewdrugapplication(IND)foritsor...lationtotreatdiabetes.ThisIND,approvalallowsBiolax...betesisadisordercharacteristicofhighbloodglucosean...sultinseveremicro-and,macro-vasculardiseases,losso...
(Date:11/24/2009)..., TORONTO,Nov.24/PRNewswire-FirstCall/-HamiltonT...eadingproviderofadvancedlasersystemsandinstruments...dayreportedoperationalandfinancialresultsforthethi...ts,-Revenuewas$1.46millioncomparedwith$1.43millio...with66.1percentinQ3,2008,-Netlossreducedto$148,000...
(Date:11/24/2009)...er24/PRNewswire/--HealthRoboticstodayannounced,tha...lected,investors.ThisrecentlyformedToronto-basedco...Inc.andwillmarket,install,andsupport,HealthRobotic...lutionaryproductofferingsi.v.STATION(TM),i.v.SOFT(...ovideassistanceonan"asneeded,basis"toitsstrategicp...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...AN DIEGO, Sept. 10 ADVENTRX Pharmaceuticals,Inc. ...elopment company,focused on commercializing propri...er and infectious diseases, announced today that i... Drug Administration (FDA) regarding its,proposed ...th for ANX-514,(docetaxel emulsion). The FDA has i...
...ompany to Hold a Conference Call Tomorrow (Tuesday...the Clinical Trial, Valley Cottage, NEW YORK, Sep...TLB ; LSE: XTL; TASE: XTL) today announced,the ini...e - a serotonin,and norepinephrine reuptake inhibi...thic pain. Bicifadine is being developed for the ...
...OUTH SAN FRANCISCO, Calif., Sept. 7 Monogram,Bios...t William D. Young, CEO,and Chairman, is scheduled...y Partners, G5: The Growth Conference on Monday, S...a.m. Pacific Time) at the St. Regis,Hotel in San F...oadcast or the subsequent archived,recording, log ...
Other Biology Technology:ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 2ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 3ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Mouse Anti-Human HVEM Cell Surface Staining Monoclonal Antibodies, Allophycocyanin Conjugated, 94801 from R&D Systems
... Osmometer for 10 L sample. Ideal for small volum...iatric, general adult, veterinary and experimental...selected values. Includes built-in printer, keypa...-keeping. Optional barcode scanner available. RS...
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: